Effect of C2-associated carbohydrate structure on Ig effector function: Studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells

Journal of Immunology

Volumn 160, Issue 7, 1998, Pages 3393-3402

  Wright, Ann ^a   Morrison, Sherie L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1;

ANIMAL CELL; ANTIBODY AFFINITY; ANTIBODY STRUCTURE; ARTICLE; CARBOHYDRATE ANALYSIS; CHIMERA; CHO CELL; COMPLEMENT ACTIVATION; CONFORMATIONAL TRANSITION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RECEPTOR AFFINITY;

ANIMALS; BINDING SITES, ANTIBODY; CARBOHYDRATE SEQUENCE; CARRIER PROTEINS; CHO CELLS; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT SYSTEM PROTEINS; CRICETINAE; CYTOTOXICITY, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC VECTORS; GLYCOSYLATION; HALF-LIFE; HUMANS; IMMUNOGLOBULIN CONSTANT REGIONS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; INJECTIONS, INTRAPERITONEAL; LECTINS; MANNOSE; MANNOSE-BINDING LECTINS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; OLIGOSACCHARIDES; PROTEIN BINDING; RECEPTORS, IGG; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 0032055988     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Nose, M., and H. Wigzell. 1983. Biological significance of carbohydrate chains on monoclonal antibodies. Proc. Natl Acad. Sci. USA 80:6632.
2. Leatherbarrow, R. J., T. W. Rademacher, R. A. Dwek, J. M. Woof, A. Clark, D. R. Burton, N. Richarden, and A. Feinstein. 1985. Effector functions of monoclonal aglycosylated mouse IgG 2a: binding and activation of complement component C1 and interaction with human Fc receptor. Mol. Immunol. 22:407.
3. Tao, M.-H., and S. L. Morrison. 1989. Studies of aglycosylated chimeric mouse-human IgG: role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J. Immunol. 143:2595.
4. Rademacher, T. W., S. W. Homans, R. B. Parekh, and R. A. Dwek. 1985. Immunoglobulin G as a glycoprotein. Biochem. Soc. Symp. 51:131.
5. Mizuochi, T., T. Taniguchi, A. Shimizu, and A. Kobata. 1982. Structural and numerical variations of the carbohydrate moiety of immunoglobulin G. J. Immunol. 129:2016.
6. Parekh, R. B., R. A. Dwek, B. J. Sutton, D. L. Fernandes, and A. Leung. 1985. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316:452.
7. Rademacher, T. W., R. B. Parekh, R. A. Dwek, D. Isenberg, G. Rook, J. Axford, and I. Roitt. 1988. The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis. Springer Semin. Immunopathol. 10:231.
8. Rademacher, T. W., R. B. Parekh, and R. A. Dwek. 1988. Glycobiology. Annu. Rev. Biochem. 57:547.
9. Axford, J. S., N. Sumar, A. Alavi, D. A. Isenberg, A. Young, K. B. Bodman, and I. M. Roitt. 1992. Changes in normal glycosylation mechanisms in autoimmune rheumatic disease. J. Clin. Invest. 89:1021.
10. Walker, M. R., J. Lund, K. M. Thompson, and R. Jefferis. 1989. Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing FcγRI and/or FcγRII receptors. Biochem. J. 259:347.
11. Pound, J. D., J. Lund, and R. Jefferis. 1993. Aglycosylated chimaeric human IgG3 can trigger the human phagocyte respiratory burst. Mol. Immunol. 30:233.
12. Tsuchiya, N., T. Endo, K. Matsuta, S. Yoshinoya, T. Aikawa, E. Kosuge, F. Takeuchi, T. Miyamoto, and A. Kobata. 1989. Effects of galactose depletion from oligosaccharide chains on immunological activities of human IgG. J. Rheumatol. 16:285.
13. Boyd, P. N., A. C. Lines, and A. K. Patel. 1995. The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H. Mol. Immunol. 32:1311.
14. Lund, J., N. Takahashi, J. D. Pound, M. Goodall, and R. Jefferis. 1996. Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains. J. Immunol. 157:4963.
15. H2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human IgG1. J. Exp. Med. 180:1087.
16. Stanley, P. 1984. Glycosylation mutants of animal cells. Annu. Rev. Genet. 18: 525.
17. Scatchard, G. 1949. The attraction of proteins for small molecules. Ann. NY Acad. Sci. 51:660.
18. Zuckier, L. S., L. Georgescu, C. J. Chang, M. D. Scharff, and S. L. Morrison. 1994. The use of severe combined immunodeficiency mice to study the metabolism of human immunoglobulin. Cancer 73(Suppl.):794.
19. Super, M. 1992. Distinct and overlapping functions of allelic forms of human mannose-binding protein. Nat. Genet. 2:50.
20. Jefferis, R., C. B. Reimer, F. Skvaril, G. deLange, N. R. Ling, J. Lowe, M. R. Walker, D. J. Phillips, C. H. Aloisio, J. P. Vaerman, C. G. Magnusson, H. Kubagawa, M. Cooper, F. Vandal, B. Vandvik, J. J. Haaijman, O. Makela, A. Sarnesto, Z. Lando, J. Gergely, E. Rajnavolgyi, G. Laszlo, J. Radl, and G. A. Molinaro. 1985. Evaluation of monoclonal antibodies having specificity for human IgG subclasses: results of an IUIS/WHO collaborative study. Immunol. Lett. 10:223.
21. Wright, A., M.-H. Tao, E. A. Kabat, and S. L. Morrison. 1991. Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure. EMBO J. 10:2717.
22. H2 domain and is modulated by the hinge region. J. Exp. Med. 173:1483.
23. Rshelson, Z., and H. J. Muller-Eberhard. 1982. C3 convertase of human complement: enhanced formation and stability of the enzyme generated with nickel instead of magnesium. J. Immunol. 129:2603.
24. Malhotra, R., M. R. Wormald, P. M. Rudd, P. B. Fischer, R. A. Dwek and R. B. Sim 1995. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Mol. Med. 1:237.
25. Hamilton, R., and S. L. Morrison. 1993. Epitope mapping of MABs with mutant chimeric antibodies. J. Immunol. Methods 158:1207.
26. Sutton, B. J., and D. C. Phillips. 1983. The three-dimensional structure of the carbohydrate within the Fc fragment of immunoglobulin G. Biochem. Soc. Trans. 11:130.
27. Tao, M.-H., R. I. F. Smith, and S. L. Morrison. 1993. Structural features of immunoglobulin G that determine isotype-specific differences in complement activation. J. Exp. Med. 178:661.
28. Thornburg, R. W., J. F. Day, J. W. Baynes, and S. R. Thorpe. 1980. Carbohydrate-mediated clearance of immune complexes from the circulation. J. Biol. Chem. 255:6820.
29. Malaise, M. G., C. Hoyoux, P. Franchimont, and P. R. Mahieu. 1990. Evidence for a role of accessible galactosyl or mannosyl residues of Fc domain in the in vivo clearance of IgG antibody-coated autologous erythrocytes in the rat. Clin. Inmmunol. Immunopathol. 54:469.
30. H3 domain interfaces are required for persistence of IgG1 in the circulation of mice. Scand. J. Immunol. 40:457.
31. Jefferis, R., J. Lund, and M. Goodall. 1995. Recognition sites on human IgG for Fc gamma receptors: the role of glycosylation. Immunol. Lett. 44:111.
32. Kumpel, B. M., T. W. Rademacher, G. A. W. Rook, P. J. Williams, and I. B. H. Wilson. 1994. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity. Hum. Antib. Hybrid. 5:143.
33. Lund, J., N. Takahashi, J. D. Pound, M. Goodall, H. Nakagawa, and R. Jefferis. 1995. Oligosaccharide-protein interactions in IgG can modulate recognition by Fc gamma receptors. FASEB J. 9:115.
34. White, K. D., M. B. Frank, S. Foundling, and F. J. Waxman. 1997. Effect of immunoglobulin variable region structure on C3b and C4b deposition. Mol. Immunol. 33:759.
35. Tandai, M., T. Endo, S. Sasaki, Y. Masuho, N. Kochibe, and A. Kobata. 1991. Structural study of the sugar moieties of monoclonal antibodies secreted by human-mouse hybridomas. Arch. Biochem. Biophys. 291:339.
36. Fujii, S., T. Nishiura, A. Nishikawa, R. Miura, and N. Taniguchi. 1990. Structural heterogeneity of sugar chains in immunoglobulin G. J. Biol. Chem. 265:6009.
37. Parekh, R. B., A. G. D. Tse, R. A. Dwek, A. F. Williams, and T. W. Rademacher. 1987. Tissue-specific N-glycosylation, site-specific oligosaccharide patterns and lentil lectin recognition of rat Thy-1. EMBO J. 6:1233.
38. Ip, C. C., Miller, W. J., Silberklang, M., Mark, G. E., Ellis, R. W., Huang, L., Glushka, J., Van Halbeek, H., Zhu, J., and Aldaheff, J. A. 1994. Structural characterization of the N-glycans of a humanized anti-CD 18 murine immunoglobulin G. Arch. Biochem. Biophys. 308:387.
39. Lund, J. N. Takahashi, H. Nakagawa, M. Goodall, T. Bentley, S. A. Hindley, R. Tyler, and R. Jefferis. 1993. Control of IgG glycosylation: a comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs. Mol. Immunol. 30:741.
40. Borys, M. C., D. I. H. Linzer, and E. T. Papoutsakis. 1993. Culture pH affects expression rates and glycosylation of recombinant mouse placental lactogen proteins by Chinese hamster ovary (CHO) cells. Biotechnology 11:720.
41. Stanley, P. 1987. Glycosylation mutants and the function of mammalian carbohydrates. Trends Genet. 3:77.